Parkinson's Disease Clinical Trials in Chicago

Showing 121-140 of 160 trials

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

NCT01744496

This trial is being conducted to compare the impact of Rotigotine and Placebo on Chronic Pain associated with Parkinson's Disease among patients with advanced stages of the disease.

Advanced Idiopathic Parkinson's Disease

UCB BIOSCIENCES GmbH68 participantsStarted Nov 2012

Gilbert, Arizona, United States • Sunnyvale, California, United States • Tampa, Florida, United States +13 more locations

TERMINATEDPhase 32.2 miles

NET-PD LS-1 Creatine in Parkinson's Disease

NCT00449865

The purpose of this trial is to determine if the nutritional supplement creatine slows the progression of Parkinson's disease over time.

Parkinson's Disease

University of Rochester1,741 participantsStarted Mar 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Fountain Valley, California, United States +47 more locations

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

NET-PD LS-1 Creatine in Parkinson's Disease

Parkinson's Disease Trials in Other Cities

The Effect of Exercise on Individuals With Parkinson's Disease

Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson's Disease

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Safety of Urate Elevation in Parkinson's Disease

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Other Conditions in Chicago